No title
- Funded by
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19start year
-99Known Financial Commitments (USD)
$0Principal Investigator
MD. Grace Lee UnspecifiedResearch Location
United States of AmericaLead Research Institution
N/AResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Prognostic factors for disease severity
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
We will isolate neutrophils from subjects who had asymptomatic/mild cases of COVID-19 who didn't require hospitalization and have recovered and from subject who had severe cases of COVID-19 that required mechanical ventilation and/or developed thrombosis. We will determine if differences in neutrophil reactivity correlate with COVID-19 severity and characterize those differences. We will use RNA sequencing to identify differences in neutrophil gene expression between the two cohorts. Based on our lab's preliminary work, our initial focus will be on genes that encode receptors and proteins in signal transduction pathways. We will also examine genes which regulate inflammatory cytokines and proteins involved in the defense response; cell-fate following phagocytosis; gene transcription, translation and DNA binding; ion channels and calcium flux; and neutrophil structure/cytoskeleton, as these have been found to be differentially expressed after activation by various receptor agonists or bacteria.